TauTona Group’s wholly owned subsidiary, Aline Aesthetics, has sold the Aline Hyaluronic acid (HA) thread technology to Allergan Inc.
The technology, which is being developed as a dermal filler, is comprised of a solid-state, cross-linked Hyaluronic acid in thread form that is attached to a needle.??
?TauTona Group is a life-science incubator and investor with expertise in surgery, aesthetics, and wound care. Recent sales included the TauTona Tissue Injector to LifeCell and the sale of its Surgical Marker technology to Novadaq® Technologies Inc.